Plasma of pregnant and preeclamptic women activates monocytes in vitro by Faas, M.M. et al.
  
 University of Groningen
Plasma of pregnant and preeclamptic women activates monocytes in vitro
Faas, M.M.; Donker, R.B.; van Pampus, M.G.; Huls, A.M.; Salomons, J.; de Vos, P.;
Aarnoudse, J.G.
Published in:
American Journal of Obstetrics and Gynecology
DOI:
10.1016/j.ajog.2007.12.013
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2008
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Faas, M. M., Donker, R. B., van Pampus, M. G., Huls, A. M., Salomons, J., de Vos, P., & Aarnoudse, J. G.
(2008). Plasma of pregnant and preeclamptic women activates monocytes in vitro. American Journal of
Obstetrics and Gynecology, 199(1), 84-88. [ARTN 84.e1]. https://doi.org/10.1016/j.ajog.2007.12.013
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the















































8ASIC SCIENCE:  OBSTETRICS
lasma of pregnant and preeclamptic
omen activates monocytes in vitro
. M. Faas, PhD; R. B. Donker, MD, PhD; M. G. van Pampus, MD, PhD;
. M. F. Huls, MSc; J. Salomons; P. de Vos, PhD; J. G. Aarnoudse, MD, PhDBJECTIVE: The objective of the study was to test the hypothesis that
actors circulating in the plasma of pregnant women and women with
reeclampsia activate monocytes.
TUDY DESIGN: Blood samples were taken from patients with early-
nset severe preeclampsia (n  9), healthy pregnant women (n  9),
nd healthy nonpregnant women (n  9). A monocytic cell line was
ncubated with the plasma for 4, 16, and 24 hours. After the incubation,
eactive oxygen species (ROS) production and intercellular adhesion
olecule (ICAM)-1 expression (protein and messenger ribonucleic
cid) were measured.
ESULTS: Plasma of both pregnant women and women with pre-002-9378/$34.00 • © 2008 Mosby, Inc. All rights reserved. • doi: 10.1016
4.e1 American Journal of Obstetrics& Gynecology JULY 2008reased the mean channel brightness (MCB) of ROS after 4 hours of
ncubation, whereas only plasma of pregnant women increased the
ercentage of cells producing ROS (after 4 and 24 hours of incuba-
ion). Plasma of pregnant women and women with preeclampsia up-
egulated the percentage of ICAM-1– expressing cells after 4 hours and
own-regulated the percentage of ICAM-1– expressing cells and MCB
fter 24 hours.
ONCLUSION: Plasma of both pregnant women and women with pre-
clampsia activated monocytes in vitro.
ey words: intercellular adhesion molecule, monocytes,
clampsia, as compared with plasma from nonpregnant women, in- preeclampsia, plasma, pregnant, reactive oxygen species
ite this article as: Faas MM, Donker RB, van Pampus MG, et al. Plasma of pregnant and preeclamptic women activates monocytes in vitro. Am J Obstet Gynecol
008;199:84.e1-84.e8.
 reeclampsia is a disorder unique topregnancy and characterized by hy-
ertension and proteinuria occurring in
he second half of pregnancy. Worldwide
t is a leading cause of morbidity and
ortality in pregnancy. Although the
athogenesis of the disease is not com-
letely understood, a generalized in-
ammatory response is suggested to play
n important role in the pathogenesis.1
he factor(s) responsible for activating
he inflammatory response are un-
nown. It has, however, been suggested
hat reduced vascular trophoblast inva-
sion and insufficient remodeling of the
spiral arteries results in abnormal pla-
centation and placental underperfu-
sion,2 This may lead to the production of
substances from the dysfunctional pla-
centa, which may systemically activate in-
flammatory cells, such as monocytes,
granulocytes, and endothelial cells. Many
substances have been proposed, such as cy-
tokines3 and syncytiotrophoblast mi-
crovillous membrane fragments.4
The generalized inflammatory response
of preeclampsia is characterized by acti-
vated endothelial cells5 and activated in-
flammatory cells.6 Various studies have
demonstrated that circulating leukocytes
are activated in preeclampsia.6-8 For in-
stance, up-regulation of the activation
marker CD11b was shown on both mono-
cytes and granulocytes of women with pre-
eclampsia as compared with normal preg-
nant women.6 Moreover, both monocytes
and granulocytes produce increased
amounts of oxygen free radicals in women
with preeclampsia as compared with nor-
mal pregnant women.6
There is also a lot of evidence for activa-
tion of endothelial cells in preeclampsia
because increased levels of von Willebrand
factor,9 endothelin,9 soluble E-selectin,
and soluble vascular cell adhesion mole-
cule (sVCAM)-15 have been found in
plasma from preeclamptic patients. There
is, however, no direct evidence for endo-
thelial cells activation in preeclampsia. A
recent study by Donker et al10 showed no
proinflammatory activation of endothelial
cells in abdominal fat, fascia, and myome-
trium biopsies of patients with preeclamp-
sia, whereas Lyall at al11 also demonstrated
no differences in proinflammatory adhe-
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www.AJOG.org Basic Science: Obstetrics Researchetrial vessels of normal pregnant and
omen with preeclampsia. This may sug-
est that endothelial cell activation in pre-
clampsia may be restricted to specialized
ascularbeds, suchas in thekidneyor liver.
Not only preeclampsia but also nor-
al pregnancy is associated with an acti-
ated inflammatory response, albeit
uch less than in patients with pre-
clampsia.6,7 Activation of monocytes
nd granulocytes has been shown by in-
reased expression of the adhesion mol-
cules CD11b andCD646 and intercellu-
ar adhesion molecule (ICAM)-112 as
ell as an increased basal production of
eactive oxygen species6 and cytokine
roduction.13 It seems unlikely that in
he inflammatory response of normal
regnancy, endothelial cells are involved
ecause in normal pregnancy, no in-
reased soluble ICAM-114,15 or sVCAM-
15 was found. It may be suggested that
he placenta is also involved in activating
he inflammatory cells during normal
regnancy because, for instance, STBMs
ave also been found in normal preg-
ancy.4 Also, other factors produced by
he placentamay be involved, such as cy-
okines.16 The reason that inflammatory
TABLE 1














Systolic blood pressure (mm Hg) 1
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Diastolic blood pressure (mm Hg)
..........................................................................................................













Faas. Plasma of pregnant women and women with preecla
2008.ells are activated during normal preg- iancy remains unknown, although it
ay be suggested that it is a compensa-
ory response for the change in Th1/Th2
alance toward Th2 during normal
regnancy.17
The present study was set up to test the
ypothesis that plasma factors of both
omen with preeclampsia and pregnant
omen activate monocytes and that
lasma factors of womenwith preeclamp-
ia induce higher monocyte activation as
ompared with plasma of normal preg-
ant women. Therefore, we used amono-
ytecell line(monomac-6cells),whichwas
ncubated for various intervals with
lasma of women with preeclampsia, ges-
ational age–matched normal pregnant
omen and age-matched nonpregnant
omen. The activational state of mono-
ytes was measured using 2 parameters,
CAM-1 expression and oxygen-free radi-
al production. Increased expression of
CAM-1onmonocyteshasbeenshownaf-
er activation of these cells with various
timuli (ie, lipopolysaccharide [LPS]).18
oreover, monocyte ICAM-1 expression
as shown tobe increased inmonocytesof
regnant women as compared with







(n  9) P value







6 (1.2) 31.3 (2) NS
..................................................................................................................
(3) 118 (3.7)  .01
..................................................................................................................




42 (0.03) 0.24 (0.02)  .01
..................................................................................................................
8 (39) 242 (13)  .01
..................................................................................................................
..................................................................................................................
3 (1.11) 38.99 (0.6)  .01
..................................................................................................................
(182) 3744 (257)  .01
..................................................................................................................
ic activates monocytes in vitro. Am J Obstet Gynecols well known that on activation of mono- t
JULY 2008 Ameriytes, they start producing reactive oxygen
pecies (ROS),20 whereas monocyte ROS
roduction is increased during pregnancy
nd preeclampsia.6 Both ICAM-1 expres-
ion and ROS production were measured
sing flow cytometry. ICAM-1 messenger
ibonucleic acid (mRNA) expression was




his study was approved by the Medical
thics Committee of the University
edical Center Groningen. Written in-
ormed consent was obtained from all
articipants. Preeclampsia was defined
ccording to the standards of the Inter-
ational Society for the Study of Hyper-
ension in Pregnancy: a diastolic blood
ressure of at least 90 mm Hg on 2 or
ore consecutive occasions, each more
han 4 hours apart, and proteinuria of
ore than 300 mg per 24 hours. Both
hould develop after 20 weeks of gesta-
ion and return to normal values within
months after delivery.
Womenwho had been diagnosed with
preexisting hypertension, diabetes
ellitus, vasculitis, chronic renal dis-
ase, autoimmune disease, or malig-
ancy and women who had undergone
ecent trauma or surgery were excluded
rom the study. For both the normal
regnancy and preeclamptic group, only
ingleton pregnancies were included. All
atients with preeclampsia (n  9) had
n early-onset development of the dis-
ase and participated between 25 and 33
eeks of gestation and at the time of
lood sampling had not been treated
ith corticosteroids.
Controls were healthy pregnant
omen without hypertension (diastolic
ess than 90mmHg and systolic less than
35 mm Hg) (n  9). They were
atched with womenwith preeclampsia
or age ( 6 years) and gestational age at
lood sampling ( 2 weeks). Nonpreg-
ant women (n 9), recruited from our
ospital staff, werematchedwithwomen
ith preeclampsia and normal pregnant
omen for age. The Table summarizes




























mpthe patients and controls.
































































































































































Research Basic Science: Obstetrics www.AJOG.org
8ollection and preparation
f plasma samples
aternal blood samples of both preg-
ant women and women with pre-
clampsia were collected during routine
lood sampling during pregnancy/pre-
clampsia. Blood samples were drawn
rom the antecubital vein into 10 mL
ubes containing lithium heparin
Venoject, Terumo Europe NV, Leuven,
elgium). Samples were immediately
tored at 4°C and centrifuged within 1
our. They were centrifuged at 130 g for
0 minutes at 4°C; subsequently the
lasma was centrifuged at 700 g for 10
inutes. The platelet poor plasma was
rozen in aliquots at80°C.
onocyte cell cultures
n this study we used the monocyte cell
ine (monomac-6 [MM6]), which is a
onocytic cell line, showing phenotypic
nd functional features ofmaturemono-
ytes.21 The reason for using this cell line,
ather than isolated peripheral blood
onocytes, is the fact that isolation of
onocytes from peripheral blood al-
eady results in activation of the mono-
ytes.22,23 The MM6 cell line was cul-
ured in culture flasks in RPMI 1640
edium, supplemented with 10% fetal
alf serum, 100 nM sodium pyruvate,
00 nM glutamate, 0.05 M -mercapto-
thanol (BME), 10 mg/mL gentamicin,
nd 2.12 g/mL Fungizone. Cells were
iluted 1:5 every 3-4 days. Only cells that
ere diluted 3-4 days before and that
ere at a concentration of about 1 106
ells/mL were used for the experiments.
onocyte incubation conditions
efore the start of the experiments,
M6 cells were centrifuged at 1800 rpm
or 10 minutes and brought at a concen-
ration of 2 106 cells/mL.
xperiment 1: LPS
esponsiveness of MM6
e first determined the ICAM-1 expres-
ion and ROS production of the MM6
ells after a strong proinflammatory
timulus (ie, LPS). Therefore, MM6 cells
2 105/mL) were stimulated with LPS
concentrations ranging from 8 g/mL
o 0.1 pg/mL) at 37°C and 5% CO2 (n
). After incubation for 4 hours, wemea-
ured oxygen-free radical production o
4.e3 American Journal of Obstetrics& GynecologPhago Burst Orpegen; Orpegen
harma, Heidelberg, Germany) using
ow cytometry as described in “FlowCy-
ometry”; pilot studies showed that pro-
uction of ROS by monocytes was most
rominent between 1 and 4 hours of in-
ubation. For ICAM-1 expression,MM6
ells were incubatedwith LPS for 4 hours
n  4) and 24 hours (n  5). After in-
ubation cells were labeled with ICAM-1
mouse antihuman ICAM-1–fluores-
ein isothiocyanate [FITC] labeled, IQ
roducts, Groningen, The Netherlands)
r isotype control (IQ Products) as de-
cribed in the following text and mea-
ured by flow cytometry as described in
Flow Cytometry”.
xperiment 2
o study the effect of factors in the
lasma of pregnant women and women
ith preeclampsia onmonocyte oxygen-
ree radical production, MM6 cells (2
05/mL) were incubated in RPMI 1640
upplemented with gentamicin and fetal
alf serum (FCS) (9%) and 15% plasma
f pregnant women (n  9), women
ith preeclampsia (n  9), or nonpreg-
ant women (n  9) or 15% FCS (for
ontrol) for 4, 16, or 24 hours in 12-well
lates. Thereafter oxygen-free radical
roduction was measured as described
n “Flow Cytometry”. In each separate
xperiment, cells were incubated with
lasmas from a woman with preeclamp-
ia, gestational age matched with plasma
rom a normal pregnant woman and age
atched with plasma from a nonpreg-
ant woman.
xperiment 3
n this third experiment, we investigated
he effects of plasma’s from the 3 groups
nMM6 ICAM-1 expression on the pro-
ein and mRNA level. Therefore, MM6
2  105/mL) were incubated in RPMI
640 supplementedwith gentamicin and
CS (9%) and 15% plasma from non-
regnant (n 9), pregnant (n 9), and
omen with preeclampsia (n  9) or
5% FCS (for control) for 4, 16, and 24
ours. After incubation, two thirds of the
ells were used to measure ICAM-1
RNA (as described below), the other
ne third formeasuring ICAM-1 protein 1




xygen-free radical production was mea-
ured using the Burst test (Phagoburst)
rom Orpegen Pharma. In brief, immedi-
tely following incubation of the cells with
lasmafor4,16,or24hours, thewellswere
ncubated for 10 minutes with the fluoro-
enic substrate dihydrorhodamine 123 ac-
ording to the manufacturer’s protocol.
hereafter the reaction was stopped and
ells were fixed by adding 2 mL lysing so-
ution supplied in the kit for 20 minutes.
hen cells were spun down (5 minutes,
800 rpm) andwashed once with washing
olution suppliedby thekit, andfinally300
L of washing solution was added. Cells
ere kept on ice andmeasured by flow cy-
ometry (Calibur, BD Biosciences, Frank-
in Lakes, NJ) within 30minutes. Percent-
ge positive cells as well as mean channel
rightness of the positive cells (as a mea-
ure of total amount of oxygen-free radi-
als produced) was calculated using Win-
ist 6.0 (Verity Software House, Topsham,
E).
CAM-1 expression
mmediately following incubation with
lasma for 4, 16, or 24 hours, one third
about 60,000 cells) of the cells in each
ell was used for measuring ICAM-1
rotein expression. These cells were di-
ided over 2 5 mL tubes and spun down
5 minutes, 1800 rpm). The supernatant
as discarded, and 1 of the 2 tubes was
ncubated with FITC-labeled anti–
CAM-1, and the other tube was incu-
ated with the isotype control for 30
inutes at room temperature in the
ark. Then 2 mL washing buffer (phos-
hate-buffered saline [PBS] with 5% bo-
ine serum albumin and 0.1% sodium
zide) was added to each tube, after
hich the tubes were centrifuged for 5
inutes at 1800 rpm. The supernatant
as discarded and a paraformaldehyde
PFA) solution was added to the cells
0.5% PFA in PBS). Cells were kept at
°C in the dark until ICAM-1 expression
as measured by flow cytometry within
4 hours. During the measurement,






































































































































www.AJOG.org Basic Science: Obstetrics Researchas used to calculate the percentage of
ositive cells as well as mean channel
rightness. Therefore, the monomac
ells were gated in a forward-sidescatter
lot and copied to a histogram. The iso-
ype control of each sample was used to
et the gate so that 99% of the cells were
egative. This gatewas then copied to the
ample stained for ICAM-1, and per-
entage positive cells and mean channel
rightness were determined.
NA isolation
he remainder of the cells of the ICAM-1
xpression experiments (about 140,000
ells) were used for measuring ICAM-1
RNA.Following incubationwithplasma
FIGURE 1
Effect of LPS on ROS
production by MM6 cells
, Percentage ROS-producing MM6 cells, ex-
ressed as percentage of unstimulated cells,
fter stimulation for 4 hours with increasing LPS
oncentrations. B, Mean channel brightness of
OS-producing MM6 cells, expressed as per-
entage of unstimulated cells, after stimulation
or 4 hours with increasing LPS concentrations.
sterisk denotes significantly increased as com-
ared with unstimulated cells (Wilcoxon, P 
05).
aas. Plasma of pregnant women and women with
reeclamptic activates monocytes in vitro. Am J Obstet
ynecol 2008.romthe3groups for 4, 16, or 24hours,we ssolated RNA from each sample using the
bsolutely RNA Microprep kit (Strat-
gene, La Jolla, Calif.) according to the
anufacturer’s protocol. The quality of
heRNAwas checked by standard gel elec-
rophoresis, and quantification was per-
ormed using the Nanodrop (Thermo
isher Scientific,Wilmington, Del.). Total




or real-time RT-PCR analysis, cellular
NA was converted into first-strand
omplementary deoxyribonucleic acid
cDNA) using Superscript III RNase H-
everse transcriptase (Invitrogen, Breda,
he Netherlands) with oligo dT primers
Promega, Leiden, The Netherlands)
nd RNase inhibitor (RNaseOUT, In-
itrogen). After the reverse transcriptase
eaction, the cDNA was diluted to 4 ng/
L. Real-time PCR amplifications were
erformed on an ABI Prism 7900HT se-
uence detection system (Applied Bio-
ystems, Applera Nederland, Nieu-
ekerk aan de Ijssel, The Netherlands).
We used specific primers sets for








The real-time PCR system included
he following: PCR cycling conditions of
0°C for 2minutes, 95°C for 10minutes,
hen 40 cycles at 95°C for 15 seconds, and
0°C for 1minute, and then melting
urve analysis was performed over the
ange of 55-95°C by monitoring iQ
YBR green fluorescence (Applied Bio-
ystems, Foster City, Calif.) with increas-
ng temperature (0.5°C increment
hanges at 10 second intervals). Specific
roducts were determined as clear single
eaks at their melting curves. All sample
easurements were performed in tripli-
ate. Sample cycle threshold (Ct) values
ere determined from plots of relative
uorescence units vs PCR cycle number
uring exponential amplification so that
ample measurement comparisons were I
JULY 2008 Ameriossible. The Ct value for ICAM-1 ex-
ression was normalized to -actin ex-
ression (delta Ct  Ct[-actin]  Ct[I-
AM-1]). The delta delta Ct value of the
arious incubation times of pregnant
nd preeclamptic plasma vs plasma from
onpregnant women was evaluated and
old change vs nonpregnant plasma
alculated.
tatistics
ll results are expressed asmean SEM.
or the first experiment (LPS-induced
OS production and ICAM-1 expres-
ion), the unstimulated cells were set to
00%. The stimulated cells were related
o the unstimulated cells. Wilcoxon
igned rank test was used to show signif-
cant differences between unstimulated
nd stimulated cells. Results were con-
idered significant if P .05.
For experiments 2 and 3, results for
onpregnant women were set to 100%;
he results for pregnant women and
omen with preeclampsia were related
o the results for nonpregnant women,
nd results for pregnant women were
ompared with results for women with
reeclampsia. Differences between
roups were tested with the Wilcoxon





timulation of MM6 cells with LPS for 4
ours with increasing LPS concentrations
esulted in an increased percentage of
M6 producing ROS (Figure 1, A). The
ercentage of cells producing ROS in-
reased dose dependently with increasing
PS concentrations. The mean channel
rightness of thepositive cells (Figure 1,B)
as increasedbyLPSstimulation from1
07 g/mL and higher. At these concen-
rations the mean channel brightness did
ot vary with the dose of LPS.
Stimulation of MM6 cells with similar
oncentrations of LPS for 4 and 24 hours
lso resulted in an increase in percentage
CAM-1–positive cells (Figure 2, A) as
ell as in increased mean channel
rightness for ICAM-1 (Figure 2, B).
igure 2A shows that the percentage of
CAM-1–positive cells was dose depen-
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8ently increased but was already maxi-
al when stimulated with 1  103
g/mL (24 hours) or 1 102g/mL (4
ours) of LPS. Also the intensity of stain-
ng (Figure 1, B) was dose dependently
ncreased by LPS stimulation from a
ose of 1 104 g/mL and higher.
xperiment 2: ROS production
fter incubation of MM6 with
lasma of nonpregnant, pregnant,
nd women with preeclampsia
OS production: Figure 3, A shows the
ercentage ROS-producing MM6 cells
fter 4, 16, or 24 hours’ incubation with
lasma fromnonpregnantwomen, preg-
FIGURE 2
Effect of LPS on ICAM-1
expression by MM6 cells
, Percentage ICAM-1–positive MM6 cells, ex-
ressed as percentage of unstimulated cells,
fter incubation with increasing concentrations
f LPS for 4 hours (triangles) and 24 hours
squares). B, Mean channel brightness of ICAM-
–positive MM6 cells, expressed as percentage
f unstimulated cells, after incubation with in-
reasing concentrations of LPS for 4 hours
triangles) and 24 hours (squares). Asterisk de-
otes significantly increased as compared with
nstimulated cells (Wilcoxon, P  .05).
aas. Plasma of pregnant women and women with
reeclamptic activates monocytes in vitro. Am J Obstet
ynecol 2008.ant women, and women with pre- o
4.e5 American Journal of Obstetrics& Gynecologclampsia, expressed as a percentage of
onpregnant plasma. The mean per-
entage of cells producing ROS after 4
ours’ incubation with plasma from
onpregnant women is 15.4 3.12. This
ercentage did not vary with incubation
ime and was not significantly different
rom cells incubated with FCS for con-
rol (mean: 14.9  3.87) (not shown in
he figure). It can be seen from the figure
hat incubation of MM6 cells with
lasma from healthy pregnant women
ignificantly increased the percentage of
ells producing ROS after 4 and 24 hours
f incubation as compared with plasma
f nonpregnant women.
Percentage ROS producing MM6 4
ours after incubation with plasma from
reeclamptic women was significantly
ecreased as compared with plasma
rom normal pregnant women and not
ignificantly different from plasma from
onpregnant women. After 24 hours’ in-
ubation with plasma of women with
reeclampsia, percentage ROS-produc-
ng MM6 cells did not differ from both
ormal pregnant women and nonpreg-
ant women. The mean channel bright-
ess (ie, the total amount of ROS per
ell) was significantly increased after 4
ours of incubation with plasma from
regnant and even further with plasma
rom women with preeclampsia as com-
ared with plasma from nonpregnant
omen (Figure 3, B).
xperiment 3: ICAM-1 expression
fter incubation of MM6
ith plasma of nonpregnant
omen, pregnant women,
nd women with preeclampsia
rotein expression
igure 4, A shows the percentage of cells
xpressing ICAM-1 following 4, 16, or 24
ours’ incubation with plasma from
onpregnant women, normal pregnant
omen, and women with preeclampsia.
esults are expressed as a percentage of
onpregnant women. Plasma from non-
regnant women slightly but signifi-
antly increased the percentage of cells
xpressing ICAM-1 as compared with
ncubationwith FCS (89.15 2%vs 85.4
3.12%, respectively; results not
hown). There was no significant effect
f time of incubation on MM6 cell w
y JULY 2008CAM-1 expression after incubation
ith plasma from nonpregnant women.
Plasma from both normal pregnant
omen and women with preeclampsia
ignificantly increased the percentage of
ells expressing ICAM-1 after 4 hours of
ncubation as compared with plasma
romnonpregnant women (Figure 4,A);
ercentage of cells expressing ICAM-1
fter incubation with plasma from
FIGURE 3





, Percentage ROS-producing MM6 cells after
, 16, and 24 hours’ incubation with plasma
rom nonpregnant women (open bars), pregnant
omen (black bars), and women with pre-
clampsia (striped bars). Results are expressed
s percentage of nonpregnant plasma. B, Mean
hannel brightness of ROS-producing MM6
ells after 4, 16, and 24 hours’ incubation with
lasma from nonpregnant women (open bars),
regnant women (black bars), and women with
reeclampsia (striped bars). Results are ex-
ressed as percentage of nonpregnant plasma.
sterisk denotes significantly increased as com-
ared with plasma from nonpregnant women
Wilcoxon, P  .05). The letter a denotes sig-
ificant change as compared with plasma from
regnant women (Wilcoxon, P  .05).
aas. Plasma of pregnant women and women with
reeclamptic activates monocytes in vitro. Am J Obstet


























































































































www.AJOG.org Basic Science: Obstetrics Researchantly increased as compared with
lasma from normal pregnant women.
fter 24 hours’ incubation, however, the
ercentage of ICAM-1 positive cells was
ignificantly decreased following incu-
ation with plasma from pregnant
omen and women with preeclampsia
s comparedwith plasma fromnonpreg-
FIGURE 4




expression by MM6 cells
, Percentage ICAM-1 positive MM6 cells after
, 16, and 24 hours’ incubation with plasma
rom nonpregnant women (open bars), pregnant
omen (black bars), and women with pre-
clampsia (striped bars). Results are expressed
s percentage of nonpregnant plasma. B, Mean
hannel brightness of ICAM-1 positive mono-
ac-6 cells after 4, 16, and 24 hours’ incubation
ith plasma from nonpregnant women (open
ars), pregnant women (black bars), and women
ith preeclampsia (striped bars). Results are
xpressed as percentage of nonpregnant
lasma. Asterisk denotes significantly increased
r decreased as compared with plasma from
onpregnant women (Wilcoxon, P  .05). The
etter a denotes significant change as compared
ith plasma from pregnant women (Wilcoxon, P
.05).
aas. Plasma of pregnant women and women with
reeclamptic activates monocytes in vitro. Am J Obstet
ynecol 2008.ant women. There was no significant mifference between plasma from women
ith preeclampsia and normal pregnant
omen.
The mean channel brightness of
CAM-1 (Figure 4, B) was significantly
ecreased following incubation with
lasma from pregnant women and
omen with preeclampsia for 24 hours
s comparedwith plasma fromnonpreg-
ant women, with no significant
ifference between plasma from normal
regnant women and women with pre-
clampsia. No difference in intensity of
taining was found between FCS incuba-
ions and plasma from nonpregnant
omen ( 85.2  6.7 vs 81.5  5.08, re-
pectively), and no effect of time of incu-
ation was observed following incuba-
ion with plasma from nonpregnant
omen (results not shown).
RNAexpression
igure 5 shows the ICAM-1 mRNA ex-
ression of MM6 cells following incuba-
ion with plasma from the 3 groups of
omen for 4, 16, and 24 hours. The fig-
re shows that ICAM-1 mRNA expres-
ion was increased after 4 hours of incu-
ation with plasma from women with
reeclampsia as compared with plasma
rom nonpregnant women and normal
regnantwomen.After 24 hours of incu-
ation, however, the ICAM-1 mRNA
as decreased after incubation with
lasma from pregnant women and
omen with preeclampsia as compared
ith plasma from nonpregnant women,
ith no difference between plasma from
omen with preeclampsia and normal
regnant women.
OMMENT
n the present study, we tested the hy-
othesis that factors circulating in the
lasma of pregnant and especially pre-
clamptic women active monocytes.
his is the first study evaluating the effect
f plasma of pregnant women and
omen with preeclampsia on monocyte
ctivation. We showed that plasma from
oth normal pregnant women and
omen with preeclampsia increased
OS production and ICAM-1 expres-
ion, suggesting activation of this mono-
yte cell line. These results are in agree-
ent with the fact that circulating c
JULY 2008 Amerionocytes in both pregnant women and
omen with preeclampsia are activated
nd produce increased amounts of ROS
nd show increased expression of
CAM-1.6,12,19 Thus, factors are present
n the plasma of both pregnant women
nd women with preeclampsia that are
ble to activate this monocyte cell line.
lthough it seems likely that such factors
rise from the placenta, the nature of
hese factors is unknown at this time and
s the subject of further research.
In the present study, we used a mono-
yte cell line, MM6. This is a monocyte
ell line with characteristics of mature
irculating monocytes.21 The reason for
hoosing to work with a cell line, rather
henwith isolated peripheralmonocytes,
s the fact that the isolation procedure of
onocytes activates the monocytes.22,23
herefore, workingwith isolated periph-
ral monocytes does not allow us to
tudy the effect of plasma on resting
onocytes.
In our first experiment, we studied the
ffect of a strongmonocyte activator, LPS,
n theMM6cells.We showed that LPS in-
FIGURE 5




expression by MM6 cells
CAM-1 mRNA expression of monomac-6 cells
fter 4, 16 and 24 hour incubation with plasma
rom nonpregnant women (open bars), pregnant
omen (black bars) and preeclamptic women
striped bars). Results are expressed as fold
hange vs nonpregnant. *Significantly increased
r decreased as compared with plasma from
onpregnant women (Wilcoxon, P  .05).
Significantly increased as compared with
lasma from pregnant women (Wilcoxon, P 
05).
aas. Plasma of pregnant women and women with
reeclamptic activates monocytes in vitro. Am J Obstet
ynecol 2008.ubation strongly increased both the pro-
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8uction of ROS and the expression of
CAM-1 dose dependently. This is in line
ith the well-known effect of LPS on
onocytes,18,20 suggesting that this cell
ine indeed responds like mature mono-
ytes and that these 2 markers (ROS pro-
uction and ICAM-1 expression)were ex-
ellentmarkers to use in our study into the
ctivating effect of plasma from pregnant
omen and womenwith preeclampsia on
onocytes.
Because we used a dose range of LPS
rom very low tomaximal in this first ex-
eriment, the results of this experiment
ere also used to give an indication of
he magnitude of the response of the
M6 cells to plasma. In the present
tudy, we used plasma of patients with
evere early-onset preeclampsia. These
atients were chosen because they
howed the most severe disease, which is
ost likely of placental origin.24 We ex-
ect themost prominent effect of plasma
rom these patients, compared with a
ilder form of the disease.
ROS production by monocytes is due
o activation of the NADPH-oxidase
nicotinamide adenine dinucleotide
hosphate-oxidase) system.25 Activa-
ion of this NADPH oxidase does result
n production of ROS for several hours,
p to 24 hours.25 The peak ROS release
oxidative burst) occursmuch earlier (ie,
etween 0 and 4 hours).25 This respira-
ory burst is the first event in full-blown
ctivation of monocytes, which can be
nduced by various monocyte activating
gents (ie, LPS, zymosan, N-formyl-L-
ethionyl-L-leucyl-L-phenylalanine, or
ytokines).20,25 After incubation of
M6 cells with plasma from both preg-
ant women and women with pre-
clampsia, the most prominent effect on
OS production was the increase of
ean channel brightness (reflecting the
ean production of ROS per cell) after 4
ours of incubation as compared with
lasma from nonpregnant women. This
ncrease in mean channel brightness af-
er incubation with plasma for 4 hours is
imilar or higher than the increase in-
uced by the maximal dose of LPS in ex-
eriment 1. Because LPS is a strong acti-
ator of monomac cells, this may
ndicate that the putative plasma fac-
or(s) is a strong activator. w
4.e7 American Journal of Obstetrics& GynecologThe fact that plasma of women with
reeclampsia induced significantlymore
OS production by monocytes as com-
ared with plasma from normal preg-
ant women is in line with previous re-
orts,6,26 which showed that basal ROS
roduction is increased in monocytes of
omen with preeclampsia vs monocytes
f normal pregnant women. This may
uggest that different activating factors
re present in preeclamptic vs normal
regnant plasma. Alternatively, in-
reased amounts of identical factorsmay
e present in the plasma of women with
reeclampsia as compared with normal
regnant women.
Also, the difference in the percentage
f MM6 cells producing ROS may sug-
est the existence of different factors in
he plasmaof both groups. After 4 and 24
ours of incubation, only plasma of
regnant women, not women with pre-
clampsia, increased the percentage of
ells producing ROS. As compared with
PS stimulation, this increase in the per-
entage of ROS-producing cells is very
light (up-regulation by plasma of 112%
nd 127% [after 4 and 24 hours’ incuba-
ion, respectively] vs maximal up-regu-
ation by LPS of 447%). However, be-
ause it may be a long-lasting effect, it
ay have physiological significance.
Also, the other monocyte activation
arker, ICAM-1, was significantly af-
ected by plasmaof pregnantwomen and
omenwith preeclampsia. After 4 hours
f incubation, plasma from pregnant
omen and plasma from women with
reeclampsia even further, significantly
ncreased the percentage of cells express-
ng ICAM-1 as compared with plasma
romnonpregnantwomen. This plasma-
nduced increase is comparable with the
aximal increase in percentage-positive
ells after LPS stimulation, which was
lso about 13%. This again suggests a
trong activating stimulus in the plasma
f both pregnant women and women
ith preeclampsia.
In accordance with the results for ROS
roduction, it may be suggested that fac-
ors that up-regulated ICAM-1 in preg-
ant and preeclamptic plasma differ be-
ause not only the percentage ICAM-1–
ositive cells was increased in women
ith preeclampsia vs normal pregnant p
y JULY 2008omen, but also this increase in protein
xpression was accompanied only by in-
reased mRNA expression in women
ndwomenwith preeclampsia. In accor-
ance with ROS production results, it
ay be suggested that factors that up-
egulated ICAM-1 in pregnant and pre-
clamptic plasma differ. This is reflected
n the fact that the percentage of ICAM-1
ositive cells was increased after incuba-
ion with preeclamptic plasma versus
regnant plasma, while only after incu-
ation preeclamptic plasma ICAM-1
RNA was increased as compared with
onpregnant plasma.
The decreased expression of ICAM-1
fter 24 hours’ incubation with plasma
rompregnant patients andpatientswith
reeclampsia was regulated at the tran-
criptional level because not only
CAM-1 protein expression but also
CAM-1 mRNA was decreased at this
ime point. The reason for this decreased
CAM-1 expression after 24 hours re-
ains unknown, whereas it is also dis-
utable whether this decrease is of bio-
ogical significance. Itmay be speculated,
owever, that the decreased ICAM-1 ex-
ression is due to an overshoot in the
echanisms decreasing monocyte
CAM-1 expression after an activational
timulus.
The present study clearly shows acti-
ation ofmonocytes (ie, amonocytic cell
ine) after incubation with plasma from
oth pregnant patients and patients with
reeclampsia. What these factors are, or
hether the factors in preeclamptic
lasma are similar (but in a different
oncentration) or different from the fac-
ors in pregnant plasma, remains un-
nown. Because poor placentation is a
redisposing factor for preeclampsia,24
t seems likely that these putative factors
re produced by the placenta.
Various factorsmay be suggested to be
esponsible for the monocyte activation.
t has been shown that syncytiotropho-
last membrane fragments (STBMs) are
eleased from the placenta during preg-
ancy but in increased amounts during
reeclampsia.27 Such STBMs may acti-
ate monocytes in both pregnancy and
reeclampsia.27 Other placental debris,
uch as soluble fetal DNA, which is


























































































































































































www.AJOG.org Basic Science: Obstetrics Researchn preeclamptic plasma, also may be in-
olved in monocyte activation.28
Other factors involved may be adeno-
ine 5=-triphosphate (ATP) and he-
opexin.29 Hemopexin, an acute-phase
eactant, which is associated with vascu-
ar permeability and inflammation,30 is
ncreased in normal pregnancy.29 ATP, a
otent activator of inflammatory cells,31
s increased during preeclampsia.29 Also,
xidized lipids,32 cytokines,3 and antian-
iogenic factors, such as soluble fms-like
yrosine kinase-1 and endoglin, have
een implicated in the inflammatory re-
ponse of preeclampsia.33
In summary, the present study showed
hat in both pregnant and preeclamptic
lasma, circulating factors are present,
hich can activate the monocyte cell line,
M6. Because this monocyte cell line re-
embles mature monocytes,21 it seems
ikely that these factors present in the
lasma of both pregnant women and
omenwithpreeclampsia also activatepe-
ipheral circulating monocytes in these
roups of women in vivo. Although the
actors remain unknown, in vivo activa-
ionof circulatingmonocytesmayresult in
ctivationof other cell types, such as endo-
helial cells. Because we have recently
hown that plasma factors do not activate
ndothelial cells directly,34 it may be sug-
ested thatmonocytes, activatedbyplasma
actors, are the initiators of the generalized
nflammatory response in pregnancy and
reeclampsia. f
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